Comparing serological and molecular profiles, we found that a proportion of 26.92% (7/26) presenting COVID-19 IgM+/IgG− had a negative PCR compared to 73.08 % (19/26) for those with a positive PCR (p < 0.0001). The gene discussed is CD40LG; the disease is COVID-19.